Q Biomed Inc.
Company Snapshot: Q Biomed Inc.
Q BioMed Inc. is a biomedical acceleration and development company. We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need.
By partnering with exceptional entrepreneurs we aim to help to create market-leading products and companies in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.
- Jan 7 2020 Q BioMed Provides a Shareholder Update Ahead of the Commercial Launch of its First Drug
- Nov 26 2019 Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator
- Nov 20 2019 Q BioMed Announces FDA Approval
- Nov 5 2019 Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline
- Oct 3 2019 Q BioMed Announces Commercial Partnership With Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United States